IRM
71
-2
SBUX
36
4
CVX
25
2
SLB
46
2
IFF
69
13
C
48
-2
GS
69
-3
L
63
3
NTAP
72
10
PFE
37
-3
GME
75
-14
RSG
67
2
DVA
73
2
CRM
57
2
MHK
55
10
VLO
45
6
SIG
79
-2
TJX
58
-3
EL
55
-3
ZBH
48
-2
IRM
71
-2
SBUX
36
4
CVX
25
2
SLB
46
2
IFF
69
13
C
48
-2
GS
69
-3
L
63
3
NTAP
72
10
PFE
37
-3
GME
75
-14
RSG
67
2
DVA
73
2
CRM
57
2
MHK
55
10
VLO
45
6
SIG
79
-2
TJX
58
-3
EL
55
-3
ZBH
48
-2
Financhill
Back

MiNK Therapeutics Stock Price Chart

Sell
46

INKT
MiNK Therapeutics

Last Price:
1.01
Seasonality Move:
19.48%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and INKT is experiencing slight buying pressure.

MiNK Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Buy
20-day SMA: 0.95 Buy
50-day SMA: 0.96 Buy
200-day SMA: 1.09 Sell
8-day EMA: 1 Buy
20-day EMA: 0.98 Buy
50-day EMA: 0.97 Buy
200-day EMA: 1.19 Sell

MiNK Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.28 Buy
Chaikin Money Flow: 115 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.88 - 1) Buy
Bollinger Bands (100): (0.85 - 1.05) Buy

MiNK Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for MiNK Therapeutics Stock

Is MiNK Therapeutics Stock a Buy?

  • MiNK Therapeutics share price is 1.01 while INKT 8-day simple moving average is 0.99, which is a Buy signal.
  • The stock price of INKT is 1.01 while MiNK Therapeutics 20-day SMA is 0.95, which makes it a Buy.
  • MiNK Therapeutics 50-day simple moving average is 0.96 while INKT share price is 1.01, making it a Buy technically.
  • INKT stock price is 1.01 and MiNK Therapeutics 200-day simple moving average is 1.09, creating a Sell signal.

INKT Technical Analysis vs Fundamental Analysis

Sell
46
MiNK Therapeutics (INKT) is a Sell

Is MiNK Therapeutics a Buy or a Sell?

  • MiNK Therapeutics stock is rated a Sell
    The current MiNK Therapeutics [INKT] share price is $1.01. The Score for INKT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.

MiNK Therapeutics Stock Info

Market Cap:
35.07M
Price in USD:
1.01
Share Volume:
68.73K

MiNK Therapeutics 52-Week Range

52-Week High:
3.34
52-Week Low:
0.75
Sell
46
MiNK Therapeutics (INKT) is a Sell

MiNK Therapeutics Share Price Forecast

Is MiNK Therapeutics Stock a Buy?

  • MiNK Therapeutics share price is 1.01 while INKT 8-day exponential moving average is 1.00, which is a Buy signal.
  • The stock price of INKT is 1.01 while MiNK Therapeutics 20-day EMA is 0.98, which makes it a Buy.
  • MiNK Therapeutics 50-day exponential moving average is 0.97 while INKT share price is 1.01, making it a Buy technically.
  • INKT stock price is 1.01 and MiNK Therapeutics 200-day simple moving average is 1.19, creating a Sell signal.

Fundamental Analysis of MiNK Therapeutics

Is MiNK Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.05 per share.

Technical Analysis of MiNK Therapeutics

Should I short MiNK Therapeutics stock?

* MiNK Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.